You are currently viewing a new version of our website. To view the old version click .

Neurotrophic Factors and Growth Factors - Historical Perspective and New Directions for Medical Use

This special issue belongs to the section “Molecular Medicine“.

Special Issue Information

Dear Colleagues,

Biomolecules invites submissions to a Special Issue focused on the chemistry, biology, and medical application of neurotrophic factors and growth factors in recognition of nature’s remarkable inspiration for gaining new ideas for future medicine.

Neurotrophic factors are a family of biomolecules that can support the growth, survival, and differentiation in the central and peripheral nerve system. Abnormalities in the expression of neurotrophic or growth factors (i.e., brain-derived neurotrophic factor, glial-cell-line-derived neurotrophic factor, epidermal growth factor, and transforming growth factor) might play a role in the pathogenesis of a variety of diseases. Numerous recent studies point to an increasing role of neurotrophic or growth factors as potential therapeutics for the treatment of a broad range of diseases.

For this Special Issue, we invite submissions focusing on understanding the challenges and opportunities for clinical development with this emerging therapeutic class.

Prof. Dr. Kenji Hashimoto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain-derived neurotrophic factor (BDNF)
  • epidermal growth factor (EGF)
  • glial-cell line-derived neurotrophic factor (GDNF)
  • nerve growth factors (NGF)
  • transforming growth factors (TGF)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomolecules - ISSN 2218-273X